Why This Was Flagged for You

Based on your VISIA Red Areas score

A clinically guided program considered when VISIA identifies an unusually low score in vascular regulation and inflammatory balance within this category.

This category reflects how effectively blood flow regulation and inflammatory signaling are managed in the periocular region — the external tissue environment surrounding the eyes. These systems influence tissue oxygenation, recovery, and tolerance to daily inflammatory and mechanical stress.

An unusually low score suggests reduced efficiency in vascular regulation and inflammatory control within this neighbouring system. While this assessment does not evaluate the eyes themselves, it can reflect shared biological stress affecting nearby tissues that rely on similar processes such as microcirculation balance, immune signaling, and tissue recovery.

When vascular regulation is less stable, surrounding tissues may experience higher baseline inflammation or delayed recovery. Over time, this can increase background tissue stress in the periocular region. For patients managing dry eye symptoms, elevated inflammatory load around the eyes may contribute to discomfort, sensitivity, or reactivity that feels persistent even when other aspects of care are improving.

Supporting inflammation balance and vascular regulation helps reduce background tissue stress and promotes a calmer external environment around the eyes. Any visible changes in redness are considered secondary indicators that underlying regulatory systems are stabilizing — not the primary goal of care.

Many Island Eyecare and Helix MedSpa treatments already support inflammatory balance and circulation indirectly. This program is considered only when review suggests that additional, targeted support may help stabilize vascular and inflammatory regulation.

If you’d like confirmation on whether your current care already addresses this area, our clinical team can review your plan with you.

Review This With Our Clinical Team

Our team can review your findings and confirm whether your current care fully addresses this program or if additional support may be needed.

How This Program Is Addressed

System-Level Focus

This program focuses on supporting vascular stability, inflammatory regulation, and tissue recovery signaling within the periocular region. When clinically indicated, targeted modalities are used to help normalize blood flow responses and reduce excess inflammatory activity.

The objective is not cosmetic redness reduction, but improved inflammatory control and vascular balance that support tissue comfort and resilience around the eyes.

Individualized Clinical Planning

Recommendations are conservative and individualized. Your symptoms, sensitivity patterns, and response to existing treatments are reviewed together before any additional inflammation-focused support is suggested. If your current care is already providing adequate regulation and comfort, no changes may be recommended.

This program is used selectively and only when it meaningfully complements your existing treatment plan.

Completion When Required

When added, this program follows defined clinical goals and reassessment points. Once inflammatory balance and vascular stability improve, care typically transitions back to maintenance within your ongoing treatment plan rather than continuing indefinitely.

If you’d like reassurance about whether this program adds value to your current care, our clinical team can walk through your findings and recommendations with you.

Confirm Your Current Plan Coverage

If you’re unsure whether your existing treatments already support this area, our clinical team can walk through it with you.

Learn More About This Program

The information below provides additional clinical context in FAQ format for patients who would like a deeper understanding of how this program works and when additional intervention may be required. Reviewing these questions is optional and not required to proceed with care.

Although this assessment does not examine the eyes themselves, it highlights how surrounding tissues manage inflammation and blood flow. Reduced regulation can increase background tissue stress, which may influence comfort around the eyes.

Often, yes. Treatments that support inflammation control, circulation, and tissue recovery frequently improve vascular regulation indirectly. This program is considered only if a clear gap remains after reviewing your response to existing care.

Some patients notice improved tolerance to environmental exposure, reduced surface sensitivity, and a more stable periocular environment. Any visible tissue changes are secondary indicators that protective systems are responding.

No. An unusually low score identifies an area to review, not a requirement for treatment. Many patients do well with their current care alone, and additional support is recommended only when it is likely to improve long-term tissue resilience.

Your existing dry eye care can continue as planned and still provide meaningful benefit. Choosing not to add this program may mean some cumulative tissue stress remains, but it does not prevent you from progressing with your current treatment pathway.

Discuss This Result With Our Clinical Team

VISIA provides a detailed, system-level view all at once. Many patients find it helpful to review these findings with our clinical team so we can clarify what matters now, what is already being addressed, and what may not require action at this time.